<html>
<head>PUBMED IDs for GSK3A</head>
<body bgcolor='#C5F0F2'><h1>GSK3A</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9515795/'>Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.</a> March 27  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/16223876/'>Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia.</a> October 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18583472/'>Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.</a> June 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20368287/'>Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.</a> November 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20824057/'>A pipeline to determine RT-QPCR control genes for evolutionary studies: application to primate gene expression across multiple tissues.</a> February 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21880219/'>A pilot study on the transcriptional response of androgen- and insulin-related genes in peripheral blood mononuclear cells induced by testosterone administration in hypogonadal men.</a> September 21  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22539113/'>Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.</a> March 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22539082/'>Deriving rules and assertions from pharmacogenomics knowledge resources in support of patient drug metabolism efficacy predictions.</a> January 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22539039/'>A shift from colon- to ileum-predominant bacteria in ileal-pouch feces following total proctocolectomy.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22539030/'>Elevated immunoreactivity against class I histone deacetylases in adenomyosis.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24984063/'>GSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis.</a> November 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25663547/'>In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response.</a> October 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27049759/'>GSK-3α Is a Novel Target of CREB and CREB-GSK-3α Signaling Participates in Cell Viability in Lung Cancer.</a> August 23  2016<br></body></html>
